Physician Information

Department : Hematology

Institue: Baskent University Adana dult BMT Center ,  EBMT CIC Number: 589 , JACIE Acrediated: T-001-2012.

Qualifications with date:

Medical Doctor-Cukurova University Medical School, Adana, Turkey: 1983

 Internist- Cukurova University Medical School, Adana, Turkey; 1990

Assistant Professor, Gaziantep University Medical School, Gaziantep, Turkey;1992

Associate Professor in Internal Medicine, Higher Education Institution, Turkey-1992

Hematologist, Baskent University Medical School,  Ankara, Turkey; 2007

Professor,  Baskent University Medical School,  Ankara, Turkey; 2010

Previous Post:         

2009-2011         Clinical Medical Director and Quality Manager, Baskent University Adana Adult BMT Unit, Adana, Turkey

2007-2008        Consultant Physician Baskent University, Baskent University Adana Adult BMT Unit, Adana, TurkeY

2007-2009        Hematologist Mersin State Hospital (Goverment Duty), Mersin, Turkey

2004-2007        Attending Physician, Baskent University Adana Adult BMT Unit, Adana,

 2007 -              Professor of Hematology/Internal Medicine Department, Baskent University, Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey. In the field of hematology, assigned as researcher and clinician on bone marrow derived stem cell transplantation and cellular therapy.

1996-2002         Team Leader Seyhan Hospital Internal Medicine Department, Adana, Turkey

2003-2204         Associate Professor in Hematology, Baskent University Adana Hospital,

1992-1995         Director, Department of Internal Medicine , Gaziantep University Medical School, Gaziantep, Turkey

1985-1990         Lecturer, Department of Internal Medicine , Gaziantep University Medical School, Gaziantep, Turkey

1985-1990         Fellowship in Internal Medicine, Çukurova Un. Medical School, Adana, Turkey

1983-1985         Physician Obligatory State Duty Ministry of Health Ihlara, Primary Health Center, Aksaray, Turkey

Summary of Current Position: Medical Director of Baskent University Adana BMT Center  2009-

Summary of Training and Experience in BMT

After completing visit to Professor Slavin's clinic in Hadassah Medical Centre; Israel on march 2004, SCT activity for adult patients began at Baskent University, Adana Hospital, Bone Marrow Unit, Adana, TURKEY. First, this activity started with autologous transplantation in 2004 and then continued together with allogeneic after 2004 without interruption from 2004 to 2015. Total SCT up to now: 520 (300 auto and 220 allo transplant   ( including Unrelated and Haploidentic BMT))  have been carried out  in the centre with my active participation. I have attended the annual EBMT Meeting, EBMT Subcomitte Meetings, and National Meetings on bone marrow transplantation and stem cell therapies, regularly.

Selected Publications

1. Boga C, Ozdogu H.Pregnancy and sickle cell disease: A review of the current literature.Crit Rev Oncol Hematol. 2015 Nov 27. pii: S1040-8428(15)30087-1. doi: 10.1016/j.critrevonc.2015.11.018.
2.  Kasar M, Asma S, Kozanoglu I, Maytalman E, Boga C, Ozdogu H, Yeral M. Effectiveness of fludarabine- and busulfan-based conditioning regimens in patients with acute myeloblastic leukemia: 8-year experience in a single center.Transplant Proc. 2015 May;47(4):1217-21.
3. Solmaz S, Gereklioğlu Ç, Tan M, Demir Ş, Yeral M, Korur A, Boğa C, Özdoğu H.A Rare Complication Developing after Hematopoietic Stem Cell Transplantation: Wernicke's Encephalopathy.Turk J Haematol. 2015 Apr 27
4. Özdoğu H, Boğa C Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.Turk J Haematol. 2015 Apr 27. doi: 10.4274/tjh.2014.0311. [Epub ahead of print]
5. Solmaz S, Özdoğu H, Boğa C.Cobalamin deficiency can mask depleted body iron reserves.Indian J Hematol Blood Transfus. 2015 Jun;31(2):255-8.
6. Yeral M, Boğa C, Oğuzkurt L, Alışkan HE, Özdoğu H, Demiroğlu YZ Tunnelled Central Venous Catheter-Related Problems in the Early Phase of Haematopoietic Stem Cell Transplantation and Effects on Transplant Outcome.Turk J Haematol. 2015 Mar 5;32(1):51-
7. Asma S, Kozanoglu I, Tarım E, Sarıturk C, Gereklioglu C, Akdeniz A, Kasar M, Turgut NH, Yeral M, Kandemir F, Boga C, Ozdogu H.Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy. Transfusion. 2015 Jan;55(1):36-44. doi: 10.1111/trf.12780. Epub 2014 Jul 29.
8. Ozdoğu H, Yeral M, Boğa C, Kozanoğlu I Use of mesenchymal cells to modulate immune suppression and immune reconstruction in a patient with aplastic anemia complicated by invasive sino-orbital aspergillosis.Turk J Haematol. 2014 Jun;31(2):181-3.
9. Solmaz S, Adan Gokbulut A, Cincin B, Ozdogu H, Boga C, Cakmakoglu B, Kozanoglu I, Baran Y Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells.Nutr Cancer. 2014;66(4):599-612.
10. Kasar M, Boğa C, Yeral M, Asma S, Kozanoglu I, Ozdogu H Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.J Thromb Thrombolysis. 2014;38(2):167-75.
11. Kozanoglu I, Kahveci S, Asma S, Yeral M, Noyan A, Boga C, Ozdogu H Plasma-exchange treatment for severe carbamazepine intoxication: a case study. J Clin Apher. 2014 Jun;29(3):178-80. doi: 10.1002/jca.21305. Epub 2013 Oct 18.
12. Yeral M, Boga C, Oguzkurt L, Asma S, Kasar M, Kozanoglu I.Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis.J Thromb Thrombolysis. 2014;37(2):97-101.
13. Guzeldemir E, Uslu Toygar H, Boga C, Cilasun U. Dental and Periodontal Health Status of Subjects with Sickle Cell Disease. Journal of Dental Sciences 2011;6:227-237
14. Boga C, Kozanoglu I, Ozdogu H, Sozer O, Sezgin N. Alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: a potential clue for restoration of pathophysiology. Transfusion and Apheresis 2010 Dec;43(3):273-9.
15. Asma S, Boga C, Ozdogu H, Serin The association of pagophagia with Helicobacter pylori infection in patients with iron-deficiency anemia. E.Int J Hematol. 2009 Jul;90(1):28-32. Epub 2009 Jun 19.
16. Asma S, Boga C, Ozdogu H Safety, therapeutic effectiveness, and cost of parenteral iron therapy..Int J Hematol. 2009 Jul;90(1):24-7. Epub 2009 Jun 3.
17. Kozanoglu I, Boga C, Ozdogu H, Sozer O, Maytalman E, Yazici AC, Sahin FI .Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification..Cytotherapy. 2009;11(5):527-33.
18. Kozanoglu I, Boga C, Ozdogu H, Maytalman E, Ovali E, Sozer O. A detachment technique based on the thermophysiological responses of cultured mesenchymal cells exposed to cold. Cytotherapy 2008; 10 (7):686-689.
19. Boga C, Kozanoglu I, Yeral M, Bakar C. Assessment of corrected QT interval in sickle cell disease patients who undergo erythroapheresis. Transfus Med. 2007 Dec; 17(6):466-472.
20. Sahin IF, Kizilkilic E, Bolukbasi T, Yilmaz Z, Boga C, Ozalp O, Karakus S, Ozdogu H.Cytogenetic findings and clinical outcomes of adult acute myeloid leukemia patients. Clinical and Experimental Medicine 2007;7(3):102-107.
21. Ozdogu H, Boga C, Kizilkilic E, Kozanoglu E, Karakus S, Sahin FI, Unalan D, Haberal M. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center. Transplant Proc. 2007 May;39(4):1257-1260.
22. Ozdogu H,  Sozer O,  Boga C, Kozanoglu I, Maytalman E, Guzey M. Flow cytometric evaluation of circulating endothelial cells: A new protocol for identifying endothelial cells at several stages of differentiation. Am J Hematol 2007 Aug;82(8):706-11.
23. Boga C, Ozdogu H, Kozanoglu I, Sozer O, Sezgin N, Kizilkilic E, Bakar C. Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis. Ther Apher Dial. 2007 Aug;11(4):255-261.
24. Ozdogu H, Boga C, Sozer O, Sezgin N, Kizilkilic E, Maytalman E, Yalcintas D. The apoptosis of blood polymorphonuclear leukocytes in sickle cell disease. Cytometry B Clin Cytom. 2007 Jul;72(4):276-280.
25.  Boga C, Kozanoglu I, Ozdogu H, Ozyurek E. Plasma exchange in critically ill patients with sickle cell disease. Transfus Apher Sci. 2007 Aug;37(1):17-22
26.  Kozanoglu I, Boga C, Ozdogu H, Sezgin N, Kizilkilic E, Kural M. Automated red cell exchange procedures ın sıckle cell disease. Transfus Apher Sci. 2007 Jun;36(3):305-12